Entrada Therapeutics (TRDA) Moves 10.4% Higher: Will This Strength Last?

Entrada Therapeutics, Inc. (TRDA) shares rallied 10.4% in the last trading session to close at $17.37. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.9% loss over the past four weeks. Last month, the company announced positive preliminary data from its phase I ENTR-601-44-101 study, which evaluated its lead pipeline candidate, ENTR-601-44, as a potential treatment for Duchenne Muscular Dystrophy. Treatment ...